Health care during administration of combined docetaxel-Mitomycin C-Vinblastin therapy in treatment of metastatic breast cancer patients [PDF]
Archive of Oncology, 2003 Background: New chemotherapy combinations are extensively investigated in metastatic breast cancer, especially in anthracycline resistant patients. However, the higher the treatment efficacy, usually the greater therapy side effects are reported.
Mitrović Jasmina +2 more
doaj +1 more source
Clinical Hematology International, 2020 Dose-adjusted rituximab, etoposide, prednisone, vincristine, cyclophosphamide and doxorubicin (DA.R-EPOCH) is used for upfront treatment of high-risk diffuse large B cell lymphoma (DLBCL).
Bhagirathbhai Dholaria +7 more
doaj +1 more source
Neoadjuvant treatment in pancreatic cance. Evidence-based medicine? A systematic review and meta-analysis [PDF]
, 2017 Neoadjuvant treatment in non-metastatic pancreatic cancer (PaC) has the theoretical advantages of downstaging the tumor, sterilizing any present systemic undetectable disease, selecting patients for surgery and administering therapy to each patient.
Antolino, Laura +10 more
core +1 more source
Management of Febrile Neutropenia - a German Prospective Hospital Cost Analysis in Lymphoproliferative Disorders, Non-Small Cell Lung Cancer, and Primary Breast Cancer [PDF]
, 2011 Background: Febrile neutropenia/leukopenia (FN/FL) is the most frequent dose-limiting toxicity of myelosuppressive chemotherapy, but German data on economic consequences are limited.
Angela Ihbe-Heffinger +19 more
core +1 more source
Associated factors of hope in cancer patients during treatment : a systematic literature review [PDF]
, 2020 Aim: To identify the associated factors of hope during treatment in cancer patients. Background: Hope is very important to cancer patients at all stages of the disease process. Hope is seen as an important coping mechanism.
Grypdonck, Maria +3 more
core +1 more source
Dental treatment considerations in the chemotherapy patient [PDF]
, 2011 Cancer patients can suffer oral toxic effects secondary to antineoplastic therapy in the form of radiotherapy and/ or chemotherapy. This risk is conditioned by a range of factors, including the high cell turnover rate of the oral mucosa, the diversity ...
Chaveli López, Begonya +2 more
core +1 more source
Adverse drug reaction: a comparative analysis of protocols used for treatment of colorectal cancer
Medicina, 2017 Study design: Cohort study Objective: Analyze the adverse reactions that occurred in Brazilian patients with colorectal cancer submitted to chemotherapy with two different protocols, in order to identify the types and severity of those most frequent ...
Marcela Maciel Melo +2 more
doaj +1 more source
Gestational trophoblastic disease [PDF]
Archive of Oncology, 2002 Gestational trophoblastic disease belongs to a spectrum of rare tumors originating from trophoblast. It spreads from the benignant disease uncomplicated partial mole to the most malignant choriocarcinoma in stage IV of disease with brain metastases ...
Živaljević Milica +4 more
doaj +1 more source
Interventions for preventing oral mucositis for patients with cancer receiving treatment [PDF]
, 2003 Background: Treatment of cancer with chemotherapy is becoming increasingly more effective but is associated with short and long-term side effects. Oral side effects remain a major source of illness despite the use of a variety of agents to prevent them ...
Bryan, Gemma +8 more
core +3 more sources
Educational interventions for the management of cancer-related fatigue in adults [PDF]
, 2016 Background: Cancer-related fatigue is reported as the most common and distressing symptom experienced by patients with cancer. It can exacerbate the experience of other symptoms, negatively affect mood, interfere with the ability to carry out everyday ...
Beller, Elaine M +5 more
core +2 more sources